Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/103961
DC FieldValueLanguage
dc.contributor.authorSaavedra, Lucas Paulo Jacinto-
dc.contributor.authorPrates, Kelly Valério-
dc.contributor.authorGonçalves, Gessica Dutra-
dc.contributor.authorPiovan, Silvano-
dc.contributor.authorMatafome, Paulo N.-
dc.contributor.authorMathias, Paulo Cezar de Freitas-
dc.date.accessioned2022-12-12T10:55:37Z-
dc.date.available2022-12-12T10:55:37Z-
dc.date.issued2021-
dc.identifier.issn2296-634X-
dc.identifier.urihttps://hdl.handle.net/10316/103961-
dc.description.abstractA new infectious disease, COVID-19, has spread around the world. The most common symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are cough and fever, but severe cases can develop acute respiratory distress syndrome. The main receptor for SARS-CoV-2 in human tissue is angiotensin-converting enzyme 2, and the lungs, heart, and kidneys are the most affected organs. Besides the inflammatory process and tissue damage, the presence of a cytokine "storm" has been related to a higher mortality rate. Other infectious viral diseases, such as Zika, chikungunya, and influenza, were associated with complications in pregnant women, such as growth restriction, malformation, preterm birth, low birth weight, miscarriage, and death, although they can also cause developmental disorders in infants and adolescents. Evidence points out that stressors during pregnancy and infancy may lead to the development of obesity, diabetes, and cardiovascular disease. Therefore, we hypothesize that COVID-19 infection during the critical phases of development can program the individual to chronic diseases in adulthood. It is important that COVID-19 patients receive proper monitoring as a way to avoid expensive costs to public health in the future.pt
dc.language.isoengpt
dc.publisherFrontiers Media S.A.pt
dc.relationNational Council for Scientific and Technological Development (CNPq), Coordination for the Improvement of Higher Education Personnel (CAPES)pt
dc.relation“It’s good to do the good”—JBSpt
dc.relationUID/NEU/04539/2013pt
dc.relationUIDB/04539/2020pt
dc.relationPOCI-01-0145- FEDER-007440pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectCOVID-19pt
dc.subjectcardiometabolic diseasept
dc.subjectSARS-CoV-2pt
dc.subjectdevelopmentpt
dc.subjectmetabolic programmingpt
dc.subjectpublic healthpt
dc.titleCOVID-19 During Development: A Matter of Concernpt
dc.typearticlept
degois.publication.firstPage659032pt
degois.publication.titleFrontiers in Cell and Developmental Biologypt
dc.peerreviewedyespt
dc.identifier.doi10.3389/fcell.2021.659032-
degois.publication.volume9pt
dc.date.embargo2021-01-01*
dc.identifier.pmid33898461-
uc.date.periodoEmbargo0pt
item.openairetypearticle-
item.fulltextCom Texto completo-
item.languageiso639-1en-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.project.grantnoCenter for Innovative Biomedicine and Biotechnology - CIBB-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.orcid0000-0002-3422-290X-
Appears in Collections:I&D ICBR - Artigos em Revistas Internacionais
I&D CIBB - Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
fcell-09-659032.pdf2.45 MBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

4
checked on Jul 15, 2024

WEB OF SCIENCETM
Citations

4
checked on Jul 2, 2024

Page view(s)

88
checked on Jul 17, 2024

Download(s)

42
checked on Jul 17, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons